Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 992 of 5804
-
New combo attack on lung tumors: immunotherapy, radiation, and surgery
Disease control Recruiting nowThis study aims to determine the safety and tolerability of combined Atezolizumab, stereotactic body radiation therapy (SBRT), and surgical resection of pulmonary metastases in patients with pulmonary recurrence of osteosarcoma
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental gene therapy offers hope for rare blindness condition
Disease control ENROLLING_BY_INVITATIONTo provide treatment options for the control group of subjects who completed the 52-week follow-up of the Phase III clinical trial (Protocol number: ZYA-2024-001) of ZVS101e in subjects with Bietti crystalline corneoretinal dystrophy (BCD).
Phase: NA • Sponsor: Chigenovo Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to bring autism support to families who need it most
Symptom relief Not yet recruitingAutism spectrum disorder affects 1-2% of children worldwide, yet access to quality care remains limited, especially in underserved communities. Families face systemic barriers such as workforce shortages, high caregiver stress, and a lack of culturally appropriate services. To a…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Can a heart procedure cut stroke risk after valve repair? new trial aims to find out
Disease control Not yet recruitingCABA-MiTRA-AFNET12 is a non-commercial, parallel-group, prospective, randomised, open, blinded endpoint assessment (PROBE), multi-centre, therapy strategy trial. The trial investigates patients with severe mitral valve regurgitation who have undergone transcatheter edge-to-edge m…
Phase: NA • Sponsor: Atrial Fibrillation Network • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Stem cell injection aims to repair kidneys in diabetes patients
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of a single intra-renal injection of allogeneic umbilical cord-derived mesenchymal stem cells (UC-MSCs) in adults with diabetic nephropathy aged 40 to 65 years. The primary questions the study aims to answer a…
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can community teamwork steer drug users away from jail and toward recovery? new study aims to find out.
Knowledge-focused Not yet recruitingThe current study proposes to use a Hybrid Type 3 implementation research strategy to: 1) Significantly enhance our understanding of public health outcomes \[e.g., overdose incidents and substance-use (SU)-related Emergency Medical Service (EMS) contacts\] and public safety outco…
Phase: NA • Sponsor: Texas Christian University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New drug hopes to strengthen muscles in rare genetic disorder
Disease control Recruiting nowThis study is testing a medicine called surlorian in adults who have a genetic muscle condition known as autosomal dominant RYR1-related myopathy (RYR1-RM). The goal is to find out whether surlorian improves muscle weakness, and whether it is safe and well tolerated.
Phase: PHASE2 • Sponsor: RyCarma Therapeutics, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could One-Time TB pill delivery stop the spread?
Prevention Not yet recruitingThe goal of this clinical trial is to learn if differentiated service delivery (DSD) of TB preventive therapy (TPT) improves uptake and completion of TPT in two populations: household contacts (HHC) of index TB patients and people living with HIV (PWH). The main questions it aims…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to stop IgG4 disease relapses without Long-Term steroids
Disease control Not yet recruitingThe goal of this clinical trial is to learn if IMM0306 works to reduce the risk of disease relapse in participants with IgG4-related disease (IgG4-RD). It will also learn about the safety and tolerability of IMM0306. The main questions it aims to answer are: * Does IMM0306 reduc…
Phase: PHASE2, PHASE3 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Breathing in medicine may stop lung bleeding faster than IV
Symptom relief Not yet recruitingThis clinical trial aims to compare two different ways of giving a medication called tranexamic acid to patients who are coughing up blood (a condition known as hemoptysis). Coughing up blood can be a serious medical issue that needs to be stopped quickly. Tranexamic acid is a we…
Phase: PHASE3 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New heart device registry aims to tame irregular heartbeat
Disease control Not yet recruitingThis post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).
Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for HIV patients who failed long-acting shots: switching to a daily pill
Disease control Not yet recruitingThis study is a pilot, multi-center, observational retrospective-prospective study, with two different Parts, as follows: 1. Part 1(retrospective and prospective part): to evaluate efficacy and safety of switching to BIC/FTC/TAF in People living with HIV (PWH) who previously fai…
Sponsor: Cristina Mussini • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Shockwaves may strengthen pelvic floor better than kegels alone
Symptom relief Not yet recruitingStress urinary incontinence (SUI) is a common pelvic floor disorder among women, especially those with a history of childbirth, aging, or pelvic surgery. Stress urinary incontinence is defined as the complaint of involuntary leakage on effort or exertion, or on sneezing or coughi…
Phase: NA • Sponsor: Suez Canal University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Personalized T-Cell therapy takes on advanced lung cancer
Disease control Not yet recruitingA Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Participants with Advanced Lung Cancer
Phase: EARLY_PHASE1 • Sponsor: Beijing Geekgene Technology Co., LTD • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Laser surgery showdown: does an extra incision improve outcomes for small prostates?
Disease control Not yet recruitingWith the increasing degree of population aging, the number of patients undergoing surgical treatment for benign prostatic hyperplasia (BPH) is steadily rising. Among them, patients with small-volume prostates (≤30 mL) represent a distinct clinical subgroup. This population has s…
Phase: NA • Sponsor: Yifeng Jing • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New Wound-Cleaning method may let surgeons close incisions right away after severe appendicitis
Disease control Not yet recruitingThe goal of this clinical trial is to compare primary wound closure (PC) versus delayed primary closure (DPC) after standardized wound decontamination using the High-Efficiency Incision and Drainage with Irrigation (HIEDI) technique in patients undergoing open appendectomy for co…
Phase: NA • Sponsor: Sana'a University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a cystic fibrosis drug boost brain blood flow in heart failure?
Disease control Recruiting nowCognitive impairment (CI) is highly prevalent in patients with heart failure with reduced ejection fraction (HFrEF), which has significant implications for disease management, quality of life and clinical outcomes. Currently, there are no specific treatments for CI aside from the…
Phase: PHASE2 • Sponsor: Qanatpharma AG • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New skin patch could speed recovery after skin cancer removal
Disease control Not yet recruitingA multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standard of sare versus standard of sare slone in the management of post-mohs micrographic surgery defects.
Phase: PHASE4 • Sponsor: BioLab Holdings • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New Eye-Tracking and brain wave tests could spot newborn brain injury hours earlier
Knowledge-focused Not yet recruitingCurrent diagnostic methods rely primarily on clinical symptoms, supplemented by brain imaging and physiological tests. However, these signs of injury only become apparent once significant damage has occurred, thus delaying intervention and compromising the effectiveness of treatm…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Experimental pill aims to knock out gout pain within hours
Symptom relief Not yet recruitingThe study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC